Solei Brand Launches New Cannabis Infused Cold Brew Teas
22 2월 2024 - 9:00PM
Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX:
TLRY), a leading global cannabis and consumer packaged goods
company, today debuts two new ready-to-drink cold brew tea
beverages by its premium cannabis wellness
brand,
Solei. Introducing
Peach
Cranberry and
Wildberry Hibiscus, Solei’s
new cold brew tea offerings are non-carbonated and embrace a
moderate elevation that’s mildly sweet and comes in 355ml per can.
Solei offers a range of versatile products and cannabinoid
formulations for consumers to explore a handful of ways to enjoy
products while socializing or unwinding. Leaning into cold brew
teas, Solei continues to expand its beverage lineup following the
success of its first-ever ready-to-drink infused beverage line
featuring Mango Passionfruit and Dragonfruit Watermelon Sparkling
CBD beverages, along with last year’s initial launch of its hot tea
collection, including the beloved Lavender Chamomile CBN tea, and
most recent fall tea editions with a spotlight on seasonal classics
such as Chai Rooibos, with high CBN content.
Solei’s newly launched cold brew teas are
produced with a black tea base and blended with real fruit juice to
create a refreshing fizz-free experience. The two new refreshing
flavours include:
- Peach Cranberry:
Made with refreshing peach and cranberry juice blended with a black
tea base and elevated with a 5mg THC and 10mg CBG infusion.
- Wildberry Hibiscus:
Wildberry Hibiscus Cold Brew Teas are made with refreshing wild
berries and hibiscus juice blended with a black tea base and
elevated with a 5mg THC and 10mg CBD infusion.
Find out more about Solei’s Cold Brew Teas by visiting
www.solei.ca and following our journey @soleicanada across socials.
Sip Solei responsibly!
About Solei
Solei is a leading cannabis wellness and lifestyle brand with
thoughtfully designed products for curating sensorial experiences
based on what you need, when you need it, entirely on your terms.
Beloved by consumers for its carefully formulated products and
innovative formats, Solei products feature varied and rare
cannabinoids that allow you to fine-tune your routines with ease.
Explore a true sense of well-being with a wide range of formats
including Solei’s best-selling CBD oils, ready-to-go pre-roll
multi-packs, blended topicals, and new beverages, along with more
exciting future launches coming later this year.
For more information on Solei,
visit http://www.Solei.ca and follow along our
journey @soleicanada on Instagram.
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY and TSX: TLRY) is a leading
global cannabis-lifestyle and consumer packaged goods company with
operations in Canada, the United States, Europe, Australia, and
Latin America that is changing people’s lives for the better – one
person at a time – by inspiring and empowering the worldwide
community to live their very best life by providing them with
products that meet the needs of their mind, body, and soul and
invoke a sense of wellbeing. Tilray’s mission is to be the trusted
partner for its patients and consumers by providing them with a
cultivated experience and health and well-being through
high-quality, differentiated brands and innovative products. A
pioneer in cannabis research, cultivation, and distribution,
Tilray’s unprecedented production platform supports over 20 brands
in over 20 countries, including comprehensive cannabis offerings,
hemp-based foods, and alcoholic beverages.
For more information on Tilray, visit Tilray Brands,
Inc. and follow @tilray on Instagram, Twitter, Facebook, and
LinkedIn.
Forward-Looking Statements
Certain statements in this communication that are not historical
facts constitute forward-looking information or forward-looking
statements (together, “forward-looking statements”) under Canadian
securities laws and within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, that are intended to
be subject to the “safe harbor” created by those sections and other
applicable laws. Forward-looking statements can be identified by
words such as “forecast,” “future,” “should,” “could,” “enable,”
“potential,” “contemplate,” “believe,” “anticipate,” “estimate,”
“plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and
the negative of these terms or similar expressions, although not
all forward-looking statements contain these identifying words.
Certain material factors, estimates, goals, projections, or
assumptions were used in drawing the conclusions contained in the
forward-looking statements throughout this communication.
Forward-looking statements include statements regarding our
intentions, beliefs, projections, outlook, analyses, or current
expectations concerning, among other things, the Company’s ability
to commercialize new and innovative products worldwide. Many
factors could cause actual results, performance, or achievement to
be materially different from any forward-looking statements, and
other risks and uncertainties not presently known to the Company or
that the Company deems immaterial could also cause actual results
or events to differ materially from those expressed in the
forward-looking statements contained herein. For a more detailed
discussion of these risks and other factors, see the most recently
filed annual information form of Tilray and the Annual Report on
Form 10-K (and other periodic reports filed with the SEC) of Tilray
made with the SEC and available on EDGAR. The forward-looking
statements included in this communication are made as of the date
of this communication and the Company does not undertake any
obligation to publicly update such forward-looking statements to
reflect new information, subsequent events, or otherwise unless
required by applicable securities laws.
Contacts:
Media:Kaitlin Macapagalnews@tilray.com
InvestorsRaphael Gross203-682-8253Raphael.Gross@icrinc.com
Tilray Brands (NASDAQ:TLRY)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Tilray Brands (NASDAQ:TLRY)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024